Jung Shin Byun
Genetics Branch, CCR
National Cancer Institute
United States of America
Dr. Jung S. Byun received her Ph.D. in chemistry and biochemistry from the University of Maryland, College Park. She pursued postdoctoral studies with Dr. Kevin Gardner at the National Cancer Institute (NCI), National Institutes of Health (NIH). During her postdoctoral residency, Dr. Byun carried out studies to define how histone acetyltransferase, p300, and the elongation factor, ELL, work in concert to control eukaryotic transcription by demonstrating the role of dynamic bookmarking by p300 RNA polymerase II complexes in transcriptional memory (Byun JS, et al. Proc Natl Acad Sci U S A 2009). She also discovered a new role for ELL (Eleven-nineteen Lysine-rich Leukemia protein), that it is required for early elongation and facilitating pol II pause site entry (Byun JS, et al. Nat Commun 2012). Dr. Byun is currently a staff scientist with Dr. Kevin Gardner’s laboratory. The lab's research interests focus on defining other potential transcription regulatory targets important in mammalian cancer cell biology that define a molecular link between metabolic imbalance and breast cancer.
1) Transcription regulatory targets, 2) cancer cell biology, 3) metabolic imbalance and breast cancer, 4) the mechanism roles of the metabolic regulators in the control of transcription during phenotypic reprogramming in breast cancer, 5) Cancer Biology, 6) Cell Biology